Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $34.7 million.

  • Relay Therapeutics' Interest & Investment Income fell 22.56% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year decrease of 12.11%. This contributed to the annual value of $34.7 million for FY2024, which is 11.92% up from last year.
  • Per Relay Therapeutics' latest filing, its Interest & Investment Income stood at $34.7 million for FY2024, which was up 11.92% from $31.0 million recorded in FY2023.
  • Relay Therapeutics' 5-year Interest & Investment Income high stood at $34.7 million for FY2024, and its period low was $830,000 during FY2021.
  • In the last 3 years, Relay Therapeutics' Interest & Investment Income had a median value of $31.0 million in 2023 and averaged $24.9 million.
  • Per our database at Business Quant, Relay Therapeutics' Interest & Investment Income slumped by 75.59% in 2021 and then skyrocketed by 958.55% in 2022.
  • Relay Therapeutics' Interest & Investment Income (Yearly) stood at $3.4 million in 2020, then slumped by 75.59% to $830,000 in 2021, then spiked by 958.55% to $8.8 million in 2022, then spiked by 253.35% to $31.0 million in 2023, then grew by 11.92% to $34.7 million in 2024.